Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cortes

Showing results (211-220 of 584) with videos related to

Pageof 59
Sort By:
Cancer|June 22, 2010
Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndromeAmit Lahoti, Hagop Kantarjian, Abdulla K Salahudeen, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor SurvivalDavid Sanford, Courtney D DiNardo, Guilin Tang, et al.
Frontiers in Public Health|December 4, 2024
Social determinants of health and upper gastrointestinal cancer outcomes in the United States: a systematic reviewBrenda Santellano, Rashi Agrawal, Gabriela Duchesne, et al.
Oncogenesis|July 4, 2017
Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cellsA J Rice, E Cortes, D Lachowski, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Multiparameter Analysis of Off-Target Effects of Dasatinib on Bone Homeostasis in Patients With Newly Diagnosed Chronic Myelogenous LeukemiaDaniela Hoehn, Jorge E Cortes, L Jeffrey Medeiros, et al.
Annals of Internal Medicine|December 15, 1996
Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trialE Ribera, J Gómez-Jimenez, E Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Phase I study of oral topotecan in hematological malignanciesMiloslav Beran, Susan O'Brien, Deborah A Thomas, et al.
Cancer|July 23, 2020
A quality-adjusted survival time without symptoms or toxicities analysis of glasdegib plus low-dose cytarabine versus low-dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapyCaitlyn T Solem, Timothy J Bell, Youngmin Kwon, et al.
Cancer|December 2, 2009
Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patientsNikolay D Dimov, L Jeffrey Medeiros, Hagop M Kantarjian, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2013
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy studyLuke P Akard, Jorge E Cortes, Maher Albitar, et al.
Pageof 59

Showing results (211-220 of 584) with videos related to

Sort By:
Pageof 59
Cancer|June 22, 2010
Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndromeAmit Lahoti, Hagop Kantarjian, Abdulla K Salahudeen, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor SurvivalDavid Sanford, Courtney D DiNardo, Guilin Tang, et al.
Frontiers in Public Health|December 4, 2024
Social determinants of health and upper gastrointestinal cancer outcomes in the United States: a systematic reviewBrenda Santellano, Rashi Agrawal, Gabriela Duchesne, et al.
Oncogenesis|July 4, 2017
Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cellsA J Rice, E Cortes, D Lachowski, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Multiparameter Analysis of Off-Target Effects of Dasatinib on Bone Homeostasis in Patients With Newly Diagnosed Chronic Myelogenous LeukemiaDaniela Hoehn, Jorge E Cortes, L Jeffrey Medeiros, et al.
Annals of Internal Medicine|December 15, 1996
Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trialE Ribera, J Gómez-Jimenez, E Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Phase I study of oral topotecan in hematological malignanciesMiloslav Beran, Susan O'Brien, Deborah A Thomas, et al.
Cancer|July 23, 2020
A quality-adjusted survival time without symptoms or toxicities analysis of glasdegib plus low-dose cytarabine versus low-dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapyCaitlyn T Solem, Timothy J Bell, Youngmin Kwon, et al.
Cancer|December 2, 2009
Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patientsNikolay D Dimov, L Jeffrey Medeiros, Hagop M Kantarjian, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2013
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy studyLuke P Akard, Jorge E Cortes, Maher Albitar, et al.
Pageof 59